niacinamide has been researched along with HIV-Associated Lipodystrophy Syndrome in 1 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
HIV-Associated Lipodystrophy Syndrome: Defective metabolism leading to fat maldistribution in patients infected with HIV. The etiology appears to be multifactorial and probably involves some combination of infection-induced alterations in metabolism, direct effects of antiretroviral therapy, and patient-related factors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nadarajah, JT | 1 |
| Collins, M | 1 |
| Raboud, J | 1 |
| Su, D | 1 |
| Rao, K | 1 |
| Loutfy, MR | 1 |
| Walmsley, S | 1 |
1 other study available for niacinamide and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Infectious complications of Bio-Alcamid filler used for HIV-related facial lipoatrophy.
Topics: Acrylic Resins; Anti-HIV Agents; Bacterial Infections; Face; Female; HIV-Associated Lipodystrophy Sy | 2012 |